United States · FDA National Drug Code directory
Cetirizine Hydrochloride Oral Solution
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 83745-185_b350aaa9-197e-4ebc-8315-6ea307dcdb2e
- Product NDC
- 83745-185
- Form
- SOLUTION
- Composition / generic term
- Cetirizine Hydrochloride Oral Solution
- Labeler
- APOZEAL PHARMACEUTICALS INC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20241220
- Source listing expiry
- 20271231
Source-listed ingredients
- CETIRIZINE HYDROCHLORIDE — 1 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 120 mL in 1 BOTTLE (83745-185-04) · 83745-185-04
- 240 mL in 1 BOTTLE (83745-185-08) · 83745-185-08
- 480 mL in 1 BOTTLE (83745-185-16) · 83745-185-16
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →